FET-PET adds 'relevant' info to pediatric cancer cases
Thanks to its high specificity, fluoroethyl-tyrosine (FET)-PET can help confirm...Read more on AuntMinnie.comRelated Reading:
Ga-68 PSMA-11 PET/MRI benefits prostate cancer patients
SNMMI: FET-PET could have answers for brainstem glioma
SNMMI: FET-PET aids pediatric brain cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 30, 2019 Category: Radiology Source Type: news
Synodos does it again: Breaking barriers to solve the 'impossible' problems
(Children's Tumor Foundation) Treatment for low-grade gliomas in patients living with neurofibromatosis type 1 are now one step closer thanks to recent research discoveries initiated and funded by the Children's Tumor Foundation. The Foundation's SYNODOS consortium has just recently been published in Nature Medicine, showing that immunotherapy has the potential to impact gliomas. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 27, 2018 Category: Cancer & Oncology Source Type: news
Artificial activation of cancer cells to destroy them
(Far Eastern Federal University) This risky method of anti-cancer therapy was suggested by scientists of Far Eastern Federal University (FEFU). Their review of mechanisms for molecular activation of stem cells of gliomas (most widely-spread brain tumors) was approved for publishing in the Frontiers in Cellular Neuroscience journal. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 26, 2018 Category: International Medicine & Public Health Source Type: news
Promising Glioma Therapy Options
Dr. James Perry speaks withCancer Network about glioma therapy options and the future of brain cancer treatment. (Source: CancerNetwork)
Source: CancerNetwork - December 22, 2018 Category: Cancer & Oncology Authors: James Perry, MD Source Type: news
AR improves operative view for robotic thyroid surgery
Researchers from South Korea have developed a technique to enhance the safety...Read more on AuntMinnie.comRelated Reading:
AR, 3D printing make headway in patient education
Virtual reality may help plan, guide glioma resection
Augmented reality heightens accuracy of brain procedure
Augmented reality guides orthopedic surgery
SIR: Holography platform boosts reader confidence for aneurysms (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 13, 2018 Category: Radiology Source Type: news
FDA to review Blue Earth's Axumin for brain cancer
The U.S. Food and Drug Administration (FDA) has accepted molecular imaging...Read more on AuntMinnie.comRelated Reading:
Blue Earth study reports Axumin can aid glioma diagnosis
Blue Earth promotes results for PET/CT agent
Blue Earth expands PSMA-PET/CT imaging portfolio
Blue Earth touts addition of Axumin to NCCN guidelines
Blue Earth highlights Axumin clinical results at ASTRO (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 11, 2018 Category: Radiology Source Type: news
'Don't come back and don't bring any friends!' Cancer patient waves goodbye to his brain tumour
James Hinnigan, 39, of Wigan, Greater Manchester, underwent pioneering surgery to remove his stage two glioma while taking part in a clinical trial at Charing Cross Hospital in 2016. (Source: the Mail online | Health)
Source: the Mail online | Health - December 6, 2018 Category: Consumer Health News Source Type: news
Liquid Biopsy Can Assess Tx Response of Peds Brain Tumors
THURSDAY, Nov. 29, 2018 -- A liquid biopsy using blood or cerebrospinal fluid (CSF) can effectively quantify changes in mutation levels among pediatric patients being treated for diffuse midline gliomas (DMGs), according to a study recently... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2018 Category: Pharmaceuticals Source Type: news
Brain tumor patient, 5, astonishes doctors by walking and talking
Rebecca Roper, five, from Enid, Oklahoma, was diagnosed with a tumor known as a glioma on her brainstem in summer 2017. Doctors were unsure if she would ever walk again. (Source: the Mail online | Health)
Source: the Mail online | Health - November 26, 2018 Category: Consumer Health News Source Type: news
Blue Earth study reports Axumin can aid glioma diagnosis
Molecular imaging firm Blue Earth Diagnostics presented new results from a...Read more on AuntMinnie.comRelated Reading:
Blue Earth promotes results for PET/CT agent
Blue Earth expands PSMA-PET/CT imaging portfolio
Blue Earth touts addition of Axumin to NCCN guidelines
Blue Earth highlights Axumin clinical results at ASTRO
Blue Earth touts Axumin reader training results (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 20, 2018 Category: Radiology Source Type: news
New drug discovery could halt spread of brain cancer
(Virginia Tech) A team of researchers at Virginia Tech may have found a solution to stopping the spread of glioblastoma with a new drug and cancer treatment method. This work is part of a five-year research grant project across multiple universities, examining the role of interstitial fluid flow in spreading glioma cells through the brain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 19, 2018 Category: International Medicine & Public Health Source Type: news
Do Bigger Brains Contribute to More Cancer?
New research published inNeuro-Oncology examines the controversial link between intracranial volume and high-grade glioma. (Source: CancerNetwork)
Source: CancerNetwork - November 16, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news
Cognitive decline -- radiation -- brain tumor prevented by temporarily shutting down immune response
(University of California - San Francisco) In a new study published Nov. 13 in the journal eLife, UC San Francisco scientists report the first animal model of glioma -- the most aggressive and most common form of brain cancer in the US -- that can also be used to study the long-term effects of radiation therapy in tumor-bearing brains. Using this mouse model, the researchers showed that a drug that temporarily suppresses a key component of the brain's immune system can prevent radiation-associated cognitive decline. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2018 Category: International Medicine & Public Health Source Type: news
Fluorescence Can ID High - Grade Glioma During Sx for Brain Tumor
Visible fluorescence shows presence of high - grade glioma cells within tumor mass during surgery (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 6, 2018 Category: Cancer & Oncology Tags: Neurology, Oncology, Pathology, Radiology, Surgery, Conference News, Source Type: news
